Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Mobilise-D
Working Group on HTA & regulatory interactions holds meeting, identifying key challenges to the use & development of digital endpoints
On 15 February, Neuronet hosted an online meeting of its Working Group on Health Technology
IDEA-FAST and Mobilise-D join forces to strengthen research and development of digital biomarkers
From January 2021 onwards, two EU Innovative Medicines Initiatives, IDEA-FAST and Mobilise-D, will join forces
Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference
In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration
#dHealth4Trials: a new channel on the use of Digital Health in regulatory clinical trials
A new discussion channel called #dHealth4Trials is now open on the In Silico World Community
European Medicines Agency supports Mobilise-D to pursue the qualification of Digital Mobility Outcomes as biomarkers
On 4 October 2019, the Innovative Medicines Initiative consortium Mobilise-D, requested qualification advice for Digital
Monitoring patients’ mobility continues despite new lockdown
Monitoring patients‘ mobility during the COVID19 pandemic could easily have been impossible due to lockdown
Spotlight on early-career investigators: a Neuronet interview with Clint Hansen
In this interview, we talk to Dr. Clint Hansen, who is deputy group leader of
Showcasing IMI projects: Neuronet at #30AEC
Neuronet has been designed to boost synergy and collaboration across the projects of the Innovative
Mobilise-D releases a new video explaining its clinical trials
The Mobilise-D project has released a new video about the Mobilise-D Clinical Study! Being able